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Abstract 
Background: Coronary heart disease is the leading cause of morbidity and 
mortality in the United States. Exercise tolerance testing has been proposed as a 
means of better identifying asymptomatic patients at high risk for coronary heart 
disease events. 
Purpose: To review the evidence on the use of exercise tolerance testing to screen 
adults with no history of cardiovascular disease for coronary heart disease. 
Data Sources: The MEDLINE database from 1966 through February 2003, hand-
searching of bibliographies, and expert input. 
Study Selection: Eligible studies evaluated the benefits or harms of exercise 
tolerance testing when added to traditional risk assessment for adults with no 
known history of cardiovascular events. 
Data Extraction: One reviewer extracted information from eligible articles into 
evidence tables, and another reviewer checked the tables. Disagreements were 
resolved by consensus. 
Data Synthesis: No study has directly examined the effect of screening 
asymptomatic patients with exercise tolerance testing on coronary heart disease 
outcomes or risk-reducing behaviors or therapies. Multiple cohort studies 
demonstrate that screening exercise tolerance testing identifies a small proportion 
of asymptomatic persons (up to 2.7% of those screened) with severe coronary 
artery obstruction who may benefit from revascularization. Several large 
prospective cohort studies, conducted principally in middle-aged men, suggest 
that exercise tolerance testing can provide independent prognostic information 
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about the risk for future coronary heart disease events (relative risk with abnormal 
exercise tolerance testing, 2.0 to 5.0). However, when the risk for coronary heart 
disease events is low, most positive findings will be false and may result in 
unnecessary further testing or worry. The risk level at which the benefits of 
additional prognostic information outweigh the harms of false-positive results is 
unclear and requires further study. 
Conclusions: Although screening exercise tolerance testing detects severe 
coronary artery obstruction in a small proportion of persons screened and can 
provide independent prognostic information about the risk for coronary heart 
disease events, the effect of this information on clinical management and disease 
outcomes in asymptomatic patients is unclear. 
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Introduction 
Coronary heart disease is the leading cause of death in the United States. Each 
year, more than 1 million Americans experience nonfatal or fatal myocardial 
infarction or sudden death from coronary heart disease. Coronary heart disease 
can also present as angina, but only 20% of acute coronary events are preceded by 
long-standing angina (I). An estimated 1 to 2 million middle-aged men have 
asymptomatic but physiologically significant coronary artery obstruction, which 
puts them at increased risk for coronary heart disease events (2, 3). The economic 
burden of coronary heart disease is also substantial. The direct and indirect costs 
of coronary heart disease in the United States are projected to total $129.9 billion 
for 2003 (I). The clinical and economic impact of coronary heart disease is the 
basis for considerable public health interest in the development of effective 
strategies to reduce the incidence of coronary heart disease events. 
In 1996, the U.S. Preventive Services Task Force considered the use of resting 
electrocardiography or exercise tolerance testing to detect asymptomatic coronary 
artery disease and prevent coronary heart disease events ( 4). The Task Force 
found insufficient evidence to recommend for or against using these tests to 
screen middle-aged and older men and women. They recommended against 
screening children, adolescents, or young adults. 
To update the evidence review and recommendations on screening for 
asymptomatic coronary artery disease, the Task Force and the Agency for 
Healthcare Research and Quality requested that the RTI International-University 
of North Carolina Evidence-based Practice Center perform an updated evidence 
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review beginning in 2001. The complete review considers resting 
electrocardiography, exercise tolerance testing, and electron-beam computed 
tomography for coronary calcium and is available at www.ahrq.gov. This article 
describes the findings on exercise tolerance testing only. The recommendations 
and rationale of the Task Force on screening for asymptomatic coronary artery 
disease are available at www.ahrq.gov (5, 6). 
Clinicians can use 2 general approaches to prevention of morbidity and mortality 
from coronary heart disease. The first approach involves screening for and 
treating the traditional modifiable risk factors for coronary heart disease, such as 
hypertension, abnormal blood levels of lipids, diabetes, cigarette smoking, 
physical inactivity, and diet. Such an approach may incorporate explicit 
calculations of the patient's risk for coronary heart disease events by using risk 
prediction equations derived from the Framingham Heart Study or other cohort 
studies (7). The second strategy involves supplementation of screening based on 
traditional risk factors with additional tests to provide further information about 
future risk for coronary heart disease or to detect severe blockages of the coronary 
arteries that might warrant treatment. 
Detection of increased risk for future coronary heart disease events may lead to 
intensified use of risk-reducing treatments. Some risk-reducing treatments are 
directed at traditional risk factors (for example, therapy with statins for 
hyperlipidemia), whereas others are not (for example, aspirin therapy). 
Revascularization by using coronary artery bypass graft surgery or percutaneous 
coronary intervention seeks to treat blockages of the coronary arteries. Whether 
5 
revascularization will reduce the risk for coronary heart disease events in persons 
identified by screening is unknown. 
Exercise tolerance testing is widely used as a diagnostic test in the initial 
evaluation of patients with symptoms suggestive of myocardial ischemia and in 
persons with previously recognized coronary heart disease. Although exercise 
tolerance testing has been applied and studied as a screening or prognostic test in 
asymptomatic persons, its utility in this group is controversial. The best measure 
of the value of screening exercise tolerance testing would come from studies that 
examined whether patients randomly assigned to undergo such tests had fewer 
coronary heart disease events or received more appropriate risk-reducing 
therapies than did patients assigned to receive treatments after standard risk factor 
assessment. 
Such direct evidence is not available. However, indirect evidence suggests that 
screening exercise tolerance testing may be helpful in guiding medical 
management (8). In the Multiple Risk Factor Intervention Trial Research study, 
high-risk male participants were randomly assigned to receive a multimodal 
intervention to reduce cardiovascular risk or usual care. Among participants with 
an abnormal baseline result on exercise tolerance testing, those who received the 
intervention had a significantly lower rate of mortality from coronary heart 
disease during follow-up than did the group that received usual care. No effect 
was seen among men with a normal baseline result on exercise tolerance testing. 
It is not clear from the report of this post-hoc analysis whether the cardiovascular 
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risk profiles of participants with an abnormal result on exercise tolerance testing 
at baseline differed significantly from those of participants with a normal result. 
Because direct evidence on possible benefits of screening exercise tolerance 
testing is lacking, we used data observational cohort studies to examine whether 
screening exercise tolerance testing could detect clinically significant 
asymptomatic obstructions of the coronary arteries or provide greater independent 
prognostic information about the risk for future coronary heart disease events than 
would be obtained solely by standard history, physical examination, and 
measurement of traditional risk factors. We also sought information about harms l 
I of screening, including the likelihood of false-positive results and the effect of labeling a person as being "at high risk." 
Methods 
Literature Review 
To identify the relevant literature, we searched the MEDLINE database from 
1966 through February 2003 by using the exploded Medical Subject Headings 
coronary heart disease, exercise test, and mass screening and the keywords 
asymptomatic and screening. We limited the search to English-language articles 
on human subjects. To supplement our literature searches, we hand-searched the 
bibliographies of key articles, used other recent systematic reviews when L 
available, and included references provided by expert reviewers that had not been 
identified by other mechanisms. 
Study Eligibility and Data Abstraction 
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Two reviewers examined the abstracts of the articles identified in the initial 
MEDLINE search and selected a subset for a full-text review. The same reviewers 
examined the full text of the selected articles to determine final eligibility. One 
reviewer extracted information from eligible articles into evidence tables, and 
another reviewer checked the tables. They resolved disagreements by consensus. 
To be eligible, studies had to have been performed in participants with no history 
of cardiovascular disease or to provide subset analysis for this group. Included 
studies on the detection of severe coronary artery obstruction reported the total 
number of persons screened to obtain the sample of persons with an abnormal 
result on exercise tolerance testing and the proportion of persons who were found 
to have coronary heart disease on angiography. The yield of exercise tolerance 
testing screening was determined by dividing the number of participants found to 
have abnormal results on angiography by the total number screened. 
For the prognostic benefit of exercise tolerance testing, included studies reported L 
the independent value of the test for predicting coronary heart disease events. We 
included studies that examined the prognostic benefit of exercise testing by using 
several different variables, including ST-segment depression, functional capacity, 
chronotropic incompetence, heart rate recovery, and development of exercise-
induced premature ventricular contractions. We also included studies that used 
nuclear medicine imaging to detect ischemia. We excluded studies that did not 
use statistical methods to control for the effect of other risk factors (such as age or 
systolic blood pressure) on the estimate of the prognostic strength of a positive 
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result on exercise tolerance testing. Table I shows information on excluded 
studies. 
The studies used different means of characterizing the prognostic benefit of 
screening with exercise tolerance testing. Many studies reported outcomes in 
terms of independent relative risk associated with a positive (versus a negative) 
screening test. Others used diagnostic test terminology, such as "sensitivity and 
specificity" or "positive predictive value." In such cases, the terms are used to 
indicate test accuracy over the entire follow-up period rather than at I point in 
time. 
To assess whether a relationship exists between sensitivity of exercise tolerance 
testing for future coronary heart disease and duration of follow-up, we examined 
the correlation between reported sensitivity and mean duration of follow-up by 
using STAT A statistical software, version 7.0 (Stata Corp., Chicago, Illinois). 
Data Summary and Quality Assessment 
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We rated the quality of the included articles according to criteria developed by the 
U.S. Preventive Services Task Force Methods Work Group (9). Tables 3 and 4 
show information only from studies judged "good." For the studies shown in 
Table 2, we considered several factors that affect quality, chiefly the percentage 
of patients with a positive exercise tolerance testing who underwent 
catheterization and how completely outcomes were assessed. We used the final 
set of eligible articles to create evidence tables and produce the larger evidence 
report, which also included evaluation of resting electrocardiography and 
electron-beam computed tomography to detect coronary calcium. The full 
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evidence report was subjected to external peer review and revised on the basis of 
the comments received; we used the revised report as the basis for this article. 
Role of the Funding Agency 
This evidence report was funded through a contract to the RTI-University of 
North Carolina Evidence-based Practice Center from the Agency for Health care 
Research and Quality. Staff of the funding agency contributed to the study design, 
reviewed draft and final manuscripts, and made editing suggestions. 
Results 
We identified 713 articles for review. We reviewed the abstracts and retained 55 
articles that examined the diagnostic or prognostic significance of screening with 
exercise tolerance testing. After full article review, we kept 31 articles 
representing 29 studies that met the inclusion criteria (10--40). We identified 
another 11 articles for inclusion through review of reference lists and input of 
expert reviewers (8, 41--50). Table 1 lists articles that were excluded during 
review of the full articles and the reason for exclusion (51--74). 
We found no studies that directly tested whether screening asymptomatic persons 
with exercise tolerance testing improves coronary heart disease and mortality. 
Similarly, we found no studies that examined the effect of screening with exercise 
tolerance testing on the subsequent use of risk-reducing interventions and 
behaviors. However, we identified fair- or good-quality observational cohort 
studies of asymptomatic adults that prospectively evaluated the value of exercise 
tolerance testing in detecting asymptomatic coronary artery obstruction (14--18, 
22, 23, 25, 27, 28, 30, 31, 38, 75) and predicting future coronary heart disease 
10 
L 
events, such as angina, myocardial infarction, and sudden death (8, I 0--!3, 19--
21, 26, 29, 32--36, 38--50). We also identified 3 good-quality studies that 
estimated the cost effectiveness of exercise tolerance testing to identify 
asymptomatic, severe, prevalent coronary heart disease (24, 28, 37). 
Exercise Tolerance Testing To Detect Asymptomatic Prevalent Disease 
We identified 13 studies in 14 articles that examined the utility of exercise 
tolerance testing to detect asymptomatic coronary artery obstruction (Table 2) 
(14, 15, 18, 22, 23, 25, 27, 28, 30, 31, 38, 75). In these studies, the prevalence of 
k_ 
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abnormal exercise tolerance testing, usually defined as exercise-induced ST-
segment depression of I mm or more, ranged from about 3% among aviators who 
were presumed healthy (16) to 29% in a sample of diabetic persons in Finland 
(15, 75). A portion of the participants with a positive exercise tolerance testing in 
each study(!% to 60%) proceeded to evaluation with cardiac catheterization. 
Screening with exercise tolerance testing yielded angiographically demonstrable 
coronary heart disease, usually defined as greater than 50% stenosis of a major 
coronary artery, in a minority of the screened patients. 
The yield of screening exercise tolerance testing was greater in higher-risk 
groups. Five studies in 6 articles evaluated diabetic persons (15, 75), those with 
multiple risk factors (18, 31 ), those with siblings with coronary heart disease (17) 
and those who were prescreened by using a chest pain questionnaire (25). In these 
studies, the yield of screening for angiographically demonstrable coronary heart 
disease ranged from 1.2% (31) to 9% (15, 18). Most cases of coronary artery 
obstruction identified by screening were single-vessel disease, but up to 2.7% of 
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screened participants had significant left main or three-vessel disease (18) and as 
many as 1.7% proceeded to revascularization after screening (25). Eight studies 
screened unselected, low-risk patients (14, 16, 22, 23, 27, 28, 30, 38). These 
studies demonstrated a yield of 0.06% to I .6% for asymptomatic coronary heart 
disease on angiography. 
Cost Effectiveness 
Three studies attempted to estimate the cost -effectiveness of screening to identify 
prevalent coronary artery obstruction. Sox and colleagues (24) used a decision-
analysis model to estimate the clinical effectiveness and cost-effectiveness of 
exercise testing in asymptomatic adults. Their model was structured so that the 
benefit of screening was achieved through detection of patients with severe 
disease who would benefit from revascularization. Only direct costs were 
considered. Levels were based on reimbursement rates at the time of the study 
(late 1980s): $165 for exercise testing, $3595 for angiography, and $31 178 for 
coronary artery bypass surgery. No discounting rate was given. Screening 60-
year-old men had a cost per life-year saved of $24 600; for 60-year-old women, 
the cost was $47 606. For persons 40 years of age, the cost-effectiveness ratios 
were much higher: $80 349 per life-year saved for men and $216 496 per life-year 
saved for women. 
The presence or absence of risk factors for coronary heart disease affected the 
cost-effectiveness ratios. The cost per life-year saved was $44 332 for 60-year-old 
men with no risk factors and $20 504 for those with 1 or more risk factors. The 
investigators concluded that routine screening was not warranted in general but 
12 
that it may be beneficial for persons at increased risk for coronary heart disease 
(for example, older men with 1 or more risk factors). An earlier cost-effectiveness 
analysis of screening exercise tolerance testing had similar findings (37). 
Pilote and colleagues (28) performed a cost analysis of data from their study of 
the clinical yield of screening exercise tolerance testing to detect unsuspected 
severe coronary artery obstruction. They sampled more than 4000 persons 
referred to the Cleveland Clinic for screening exercise tolerance testing. Data on 
cost were obtained from 1994 Medicare reimbursement rates: $110 for exercise 
testing, $1780 for angiography, and $27 270 for coronary artery bypass surgery. 
Screening identified 19 patients with severe coronary artery obstruction (0.44% of 
the cohort); of these, 14 had subsequent coronary artery bypass graft surgery. The 
investigators estimated a cost of $39 623 to identifY 1 case of severe coronary 
artery disease by screening exercise tolerance testing. The estimated cost per year 
oflife saved was $55 274. 
On the basis of these studies, it appears that screening with exercise treadmill 
testing and performing bypass surgery on persons with severe obstructions is 
relatively cost effective compared with other, better-accepted types of preventive 
care, such as mammography in women 50 to 69 years of age (76). 
Exercise Tolerance Testing as a Prediction Tool for Risk for Coronary Heart 
Disease Events 
Exercise tolerance testing can be used to provide information about a person's 
risk for a future coronary heart disease event that may augment the predictive 
ability of traditional risk assessment. Better risk assessment may help clinicians 
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and patients make better decisions about interventions for intermediate- and long-
term risk reduction. 
ST-Segment Response 
Traditionally, studies of the predictive value of exercise tolerance testing on 
future coronary heart disease have examined ST -segment response to exercise as 
the risk predictor. Most of these studies reported the total number of coronary 
heart disease events (fatal and nonfatal myocardial infarction, new-onset stable or 
unstable angina, and coronary death) as their main outcome. Others reported 
death from coronary heart disease or from all causes as the main outcome or as 
secondary outcomes. The mortality rate from coronary heart disease, and 
particularly the total mortality rate, may be less subject to ascertainment bias than 
is the total number of coronary heart disease events and hence may be more valid 
measures. However, whether from coronary heart disease or other causes, death is 
uncommon in the generally healthy, asymptomatic patients enrolled in these 
studies, making it difficult to estimate the ability of exercise tolerance testing to 
predict such events. 
We identified 15 studies in 18 articles that examined the relationship between ST 
segment response to exercise and risk for future coronary heart disease events 
(Table 2) (8, 11--13, 19--21,26,29,32, 33, 36, 39--42,45, 50). Thirteen of these 
studies (in 16 articles) found that ST -segment response during exercise predicted 
future coronary heart disease events (8, 11--13, 19--21,26,29,33,36,39--41,45, 
50). In 1 of these studies, only coronary heart disease events occurring during 
exercise was considered as the outcome (12); we therefore excluded it from 
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analysis of the predictive utility for coronary heart disease events . Two studies 
found that ST-segment response to exercise alone did not predict future coronary 
heart disease events (32, 42). 
Of the studies that found ST -segment response to be predictive of future coronary 
heart disease events, 6 (published in 8 articles) selected persons for participation 
on the basis of the presence of I or more risk factors: diabetes (13), multiple risk 
factors (8, 33, 39, 50), hyperlipidemia (26, 41), and sedentary lifestyle and obesity 
(29). The prevalence of an abnormal exercise tolerance testing, usually defined as 
ST-segment depression of I mm or more, ranged from 12% to 52%. After 
adjustment for other risk factors, the independent relative risk for coronary heart 
disease events associated with an abnormal ST -segment response to exercise in 
these higher-risk groups ranged from 3.5 (8, 50) to 21.0 (13). Sensitivity for 
occurrence of coronary heart disease events over the duration of the studies (3 to 8 
years) ranged from 30% to 100%. The positive predictive value of an abnormal 
exercise tolerance testing ranged from 7.1% (26, 41) to 46% (29). 
Seven studies (published in 8 articles) found ST-segment response to exercise to 
be predictive of future coronary heart disease events in an unselected, low-risk 
sample (11, 19--21,33,36,40, 45). The prevalence of an abnormal test tended to 
be lower than that in the higher-risk sample, ranging from 3% (33) to 20% (11, 
21 ). The independent relative risk for coronary heart disease events associated 
with an abnormal exercise tolerance testing ranged from 1.6 (40) to 21 (33), with 
the majority of the values between 2.0 and 5.0. Gibbons and colleagues (33) 
reported a higher relative risk in low-risk persons (21.0) than did the other 
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investigators; however, the absolute event rate was low (0.08 to 2.8 events/1000 
person-years) and the confidence interval was wide (6.9 to 63.3). The sensitivity 
of exercise tolerance testing for coronary heart disease events was 10% ( 45) to 
70% (11, 21). The positive predictive values ranged from 2.2% (33) to 24% (19). 
Two of the studies added nuclear perfusion imaging to exercise 
electrocardiography (19, 32). These studies reported positive predictive values of 
about 50%. However, imaging is likely to increase screening program costs (19, 
32). 
As might be expected, the sensitivity of an abnormal exercise tolerance testing 
decreased as the duration of follow-up increased (r = -0.56). Data from these 
cohort studies suggest that the majority of asymptomatic persons with an 
abnormal exercise tolerance testing do not go on to have coronary heart disease 
events, at least within the time frame of follow-up. Persons who do have events 
often develop angina rather than experience myocardial infarction or sudden 
death. The prevalence of an abnormal result on exercise tolerance testing and its 
predictive value among asymptomatic persons is greater in those at higher risk. 
These data are consistent with those of other investigators and policymakers who 
have suggested that the value of exercise tolerance testing is greater when it is 
applied to patients with 1 or more risk factors for coronary heart disease because 
selection of a higher-risk cohort for screening increases the prevalence of disease 
and positive predictive value (1 0). Bruce and associates (1 0) reported that in the 
Seattle Heart Watch Study of 4158 asymptomatic men and women, a positive 
result on exercise tolerance testing in the absence of risk factors provided little 
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predictive value. However, among patients with 1 or more other risk factors for 
coronary heart disease, the occurrence of 2 different types of abnormal response 
to exercise tolerance testing (exercise risk predictors) was associated with a 15-
fold increase in risk compared with patients who had a normal result. 
Other Exercise Predictors 
More recent studies of the value of exercise testing in asymptomatic persons have 
examined the utility of other exercise-associated risk markers, including 
functional capacity, chronotropic incompetence, heart rate recovery, and 
development of exercise-induced premature ventricular contractions, for 
predicting patients' risk for coronary heart disease events or death (Table 3) (21, 
34, 35, 42--49). In contrast to ST-segment response, these exercise indicators may 
not directly detect ischemic myocardium, but they probably indicate other 
cardiovascular derangements, such as abnormal autonomic regulation, that predict 
coronary heart disease events. In general, these findings are associated with 
moderate increases in risk for coronary heart disease after adjustment for other 
risk factors for coronary heart disease (relative risk, 1.7 to 3.5). Some factors are 
common: For example, failure to achieve target heart rate was noted in 21% of 
patients in the Framingham Offspring Study (44). 
Exercise Tolerance Testing in Women 
Two recent studies contribute important information on the predictive value of 
exercise tolerance testing in asymptomatic women ( 42, 43). The majority of other 
studies that we identified did not include women or did not provide subgroup 
analysis of the predictive value of screening exercise tolerance testing for women. 
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Mora and colleagues ( 42) analyzed data from the female participants in the Lipid 
Research Clinics Prevalence Study, many of whom had hyperlipidemia. They 
found that unlike in studies whose samples comprised predominantly men, ST-
segment response did not predict future risk for coronary heart disease events 
(relative risk, 0.88 [95% CI, 0.48 to 1.61]) in women (42). Low exercise capacity, 
along with low heart rate recovery after exercise, was an independent predictor of 
death from coronary heart disease (relative risk, 3.52 [95% CI, 1.57 to 7.86) and 
of all-cause death (relative risk, 2.11 [95% CI, 1.47 to 3.04]) in women. 
Gulati and coworkers (43) sampled asymptomatic female volunteers living in the 
Chicago area. They found that exercise capacity predicts risk for all-cause death 
in women. For every increase in exercise capacity of I metabolic equivalent, the 
relative risk for death was 0.83 (95% CI, 0.78 to 0.89). The predictive utility of 
exercise markers other than ST-segment response in these 2 studies of women is 
consistent with the results of similar studies in which most participants were men. 
Exercise Tolerance Testing before Beginning an Exercise Program 
Exercise tolerance testing is frequently used as part of an evaluation of middle-
aged persons before they begin an exercise program. Few data are available to 
determine the effectiveness of this approach in reducing the risk for activity-
related coronary heart disease events. Siscovick and colleagues (12) analyzed the 
effectiveness of exercise tolerance testing to predict activity-related coronary 
heart disease events in the Lipid Research Clinics cohort of asymptomatic 
hypercholesterolemic men. After an initial exercise tolerance test, the cohort was 
followed for an average of 7.4 years; during that time, the investigators used 
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retrospective record review to identify coronary heart disease events that were 
associated with moderate or intense activity. The cumulative incidence of 
activity-related coronary heart disease events during follow-up was 2%. An 
abnormal ST -segment response to exercise at the time of entry into the study was 
associated with a relative risk of 2.6 (95% CI, 1.3 to 5.2) for activity-related 
coronary heart disease events. The sensitivity of exercise testing for predicting the 
events was 18%, and the predictive value of a positive test for coronary heart 
disease events during exercise was 4%. Of the persons who had an activity-
associated coronary heart disease event, 80% had an initially normal ST -segment 
response to exercise; 94% of persons with abnormal ST-segment response to 
exercise did not have an activity-associated event during follow-up. Thus, 
exercise testing appears to have limited ability to detect persons who will have 
exercise-related coronary heart disease events. 
Adverse Effects of Screening Exercise Tolerance Testing 
Other than information on the frequency of false-positive results, we found no 
studies that examined the potential harms of screening. No study reported rates of 
complications from angiography of asymptomatic persons, measures of anxiety 
from knowledge of an abnormal test result, or adverse events from medical 
therapy initiated because of an abnormal test result. 
Discussion 
We identified no randomized trials that examined the effect of screening exercise 
tolerance testing to guide management and improve health outcomes of coronary 
heart disease or affect the use of risk-reducing treatments in asymptomatic adults. 
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Exercise tolerance testing of asymptomatic persons rarely detects previously 
unrecognized, clinically important coronary artery obstruction (up to 2.7% of 
screened persons). It does provide some independent prognostic information in at 
least some persons (relative risk of about 2.0 to 5.0 for coronary heart disease 
events associated with an abnormal result) above and beyond the prognostic 
information that can be gained from traditional assessment of risk factors. The 
effect of this additional information on clinical decision making, however, has not 
been studied. The potential benefits of screening exercise tolerance testing are 
likely to be small for groups in which the prevalence of the disease is low, such as 
young adults; such screening would also produce many cases of false-positive 
results. In such cases, the costs and harms associated with additional testing may 
exceed any benefits from screening. 
The value of screening exercise tolerance testing rests in large part on the 
underlying incidence of coronary heart disease events and the prevalence of 
serious artery obstructions in the screened sample. Exercise tolerance testing will 
probably perform better when applied to higher-risk groups, such as persons with 
1 or more risk factors coronary heart disease. Selection of a higher-risk group for 
screening increases the prevalence of disease in those screened and, thus, the 
predictive value of a positive test result. Whether the benefits of such tests exceed 
the disadvantages, including costs, in higher-risk groups is still unclear at present 
and requires investigation. 
For persons at low risk for coronary heart disease events, a positive result on 
exercise tolerance testing is much more likely to be false positive than true 
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positive. False-positive results in this context are concerning because they can 
lead to unnecessary, and possibly injurious, additional procedures. 
Screening has been advocated for people with high-risk occupations, but we did 
not identify new studies on the effect of screening such patients. Data from 
studies of patients with known coronary heart disease but no ischemic symptoms 
suggest that treatment with medications, such as ~-blockers, or revascularization 
can improve outcomes over no treatment, but whether patients with no history of 
coronary heart disease would have the same results is unclear (77). 
Exercise tolerance testing can be normal or nondiagnostic in an important 
proportion of patients who will experience a coronary heart disease event, as 
evidenced by the sensitivity values of 10% to 74% in the studies that evaluated 
ST-segment depression as a risk marker (Table 3). In a defined cohort of low-risk 
patients, a larger absolute number of coronary heart disease events occurs among 
those with an initially normal result on exercise tolerance testing than among 
those with an initially abnormal result. The suboptimal sensitivity of ST -segment 
response for predicting coronary heart disease events may be explained in part by 
the fact that ST-segment depression on exercise tolerance testing detects ischemia 
from obstructed coronary arteries, but many acute coronary heart disease events 
result from sudden occlusion of a previously nono bstructed segment of artery 
(78). Use of other measures from the exercise test that are not as dependent on 
identification of atherosclerotic obstructions may mitigate this dilemma (79). 
The primary tangible harm of screening exercise tolerance testing is the potential 
for medical complications related to cardiac catheterization done to further 
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evaluate a positive result. Coronary angiography is generally considered a safe 
procedure. Of all persons undergoing outpatient coronary angiography, however, 
an estimated 0.08% will die as a result of the procedure and 1.8% will experience 
a complication (80). Complications of coronary angiography include myocardial 
infarction, stroke, arrhythmia, dissection of the aorta and coronary artery, 
retroperitoneal bleeding, femoral artery aneurysm, renal dysfunction, and 
systemic infection. Rates of complications are likely to be somewhat lower in 
asymptomatic persons, but no good data are available. A positive result on 
exercise tolerance testing may also be an impetus to initiate risk-reducing therapy; 
hence, another potential harm of screening is use of with such therapies as aspirin 
or statins to overtreat persons who would not otherwise require treatment (that is, 
would be considered low risk) if they did not have an abnormal result on exercise 
tolerance testing. Other potential harms, including the psychological 
consequences of a false-positive test result, also have not been well studied. 
Our findings are consistent with those ofthe American Heart 
Association/ American College of Cardiology expert panel, which also examined 
the effectiveness of screening exercise tolerance testing (33). They recommended 
against routine exercise tolerance testing in asymptomatic adults because of 
concerns about the positive and negative predictive value of screening exercise 
tolerance testing and the potential harms of false-positive results. The American 
Heart Association/ American College of Cardiology found that screening exercise 
tolerance testing for persons with multiple risk factors to guide to risk-reduction 
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therapy or for sedentary middle-aged adults who wish to start a vigorous exercise 
program is controversial but potentially beneficial. 
Further studies are required to determine the balance of benefits and harms of 
screening exercise tolerance testing for patients with different degrees of risk for 
coronary heart disease. An adequately powered randomized trial of screening 
exercise tolerance testing compared with management based on traditional risk 
factors would greatly inform clinical decision making. Such a study should 
compare a traditional global coronary heart disease risk assessment tool to a 
screening strategy that also incorporates exercise tolerance testing. A broad 
spectrum of patients should be enrolled, including a sufficient number of women. 
Studies examining how providers and patients actually apply the additional 
information from exercise tolerance testing will also be helpful. Finally, better 
information about the adverse effects of screening is required if researchers are to 
perform well-informed cost-effectiveness analyses of exercise tolerance testing 
screening plus risk factor-based decision making compared with risk-factor-based 
decision making alone. 
23 
References 
I. American Heart Association. Heart Disease and Stroke Statistics---2003 
Update. Dallas, TX, American Heart Association; 2002. 
2. Thaulow E, Erikssen J, Sandvik L, Erikssen G, Jorgensen L, Cohn PF. Initial 
clinical presentation of cardiac disease in asymptomatic men with silent 
myocardial ischemia and angiographically documented coronary artery disease 
(the Oslo Ischemia Study). Am J Cardiol. 1993;72:629-33. [PMID: 8249835] 
3. Cohn PF. Detection and prognosis of the asymptomatic patient with silent 
myocardial ischemia. Am J Cardiol. 1988;61:4B-6B. [PMID: 3277364] 
4. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. 
2nd ed. Alexandria, VA: International Medical Publishing; 1996. 
5. Fowler-Brown A, Pignone M, Pletcher M, Tice JA, Sutton SF, Lohr KN. 
Exercise Tolerance Testing to Screen for Coronary Heart Disease in 
Asymptomatic Adults: A Systematic Review for the U.S. Preventive Services 
Task Force. Produced by the RTI-UNC EPC. Evidence Report/Technology 
Assessment Number [to be provided by AHRQ]. Rockville, MD: Agency for 
Healthcare Research and Quality; [In press]. 
6. U.S. Preventive Services Task Force. Exercise Tolerance Testing to Screen for 
Coronary Heart Disease in Asymptomatic Adults: Recommendations and 
Rationale Statement ofthe U.S. Preventive Services Task Force. Rockville, MD: 
Agency for Health care Research and Quality; [In press]. 
24 
7. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel 
WB. Prediction of coronary heart disease using risk factor categories. Circulation. 
1998;97:1837-47. [PMID: 9603539] 
8. Exercise electrocardiogram and coronary heart disease mortality in the Multiple 
Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research 
Group. Am J Cardiol. 1985;55:16-24. [PMID: 2857061] 
9. Harris RP, Helfand M, WoolfSH, Lohr KN, Mulrow CD, Teutsch SM, eta!. 
Current methods of the US Preventive Services Task Force: a review of the 
process. Am J Prev Med. 2001;20:21-35. [PMID: 11306229] 
10. Bruce RA, Hossack KF, DeRouen TA, Hofer V. Enhanced risk assessment for 
primary coronary heart disease events by maximal exercise testing: I 0 years' 
experience of Seattle Heart Watch. JAm Coli Cardiol. 1983;2:565-73. [PMID: 
6875120] 
11. Josephson RA, Shefrin E, Lakatta EG, Brant LJ, Fleg JL. Can serial exercise 
testing improve the prediction of coronary events in asymptomatic individuals? 
Circulation. 1990;81 :20-4. [PMID: 2297826] 
12. Siscovick DS, Ekelund LG, Johnson JL, Truong Y, Adler A. Sensitivity of 
exercise electrocardiography for acute cardiac events during moderate and 
strenuous physical activity. The Lipid Research Clinics Coronary Primary 
Prevention Trial. Arch Intern Med. 1991;151:325-30. [PMID: 1992960] 
13. Rutter MK, W ahid ST, McComb JM, Marshall SM. Significance of silent 
ischemia and microalbuminuria in predicting coronary events in asymptomatic 
25 
patients with type 2 diabetes. JAm Coli Cardiol. 2002;40:56-61. [PMID: 
121 03256] 
14. Boyle RM, Adlakha HL, Mary DA. Diagnostic value of the maximal ST 
segment/heart rate slope in asymptomatic factory populations. J Electrocardiol. 
1987;20 Suppl:128-34. [PMID: 3320257] 
15. Koistinen MJ. Prevalence of asymptomatic myocardial ischaemia in diabetic 
subjects. BMJ. 1990;301 :92-5. [PMID: 2390590] 
16. Piepgrass SR, Uhl GS, Hickman JR Jr, Hopkirk JA, Plowman K. Limitations 
of the exercise stress test in the detection of coronary artery disease in apparently 
healthy men. Aviat Space Environ Med. 1982;53:379-82. [PMID: 7082255] 
17. Blumenthal RS, Becker DM, Y anek LR, Aversano TR, Moy TF, Kral BG, et 
al. Detecting occult coronary disease in a high-risk asymptomatic population. 
Circulation. 2003;107:702-7. [PMID: 12578872] 
18. Massie BM, Szlachcic Y, Tubau JF, O'Kelly BF, AmmonS, Chin W. 
Scintigraphic and electrocardiographic evidence of silent coronary artery disease 
in asymptomatic hypertension: a case-control study. JAm Coli Cardiol. 
1993 ;22: 1598-606. [PMID: 8227826] 
19. Fleg JL, Gerstenblith G, Zonderman AB, Becker LC, Weisfeldt ML, Costa PT 
Jr, et al. Prevalence and prognostic significance of exercise-induced silent 
myocardial ischemia detected by thallium scintigraphy and electrocardiography in 
asymptomatic volunteers. Circulation. 1990;81:428-36. [PMID: 2297853] 
20. Laukkanen JA, Kurl S, Lakka TA, Tuomainen TP, Rauramaa R, Salonen R, et 
al. Exercise-induced silent myocardial ischemia and coronary morbidity and 
26 
mortality in middle-aged men. JAm Col! Cardiol. 2001 ;38:72-9. [PMID: 
11451298] 
21. Rywik TM, O'Connor FC, Gittings NS, Wright JG, Khan AA, Fleg JL. Role 
of nondiagnostic exercise-induced ST -segment abnormalities in predicting future 
coronary events in asymptomatic volunteers. Circulation. 2002;106:2787-92. 
[PMID: 12451004] 
22. Livschitz S, Sharabi Y, Yushin J, Bar-On Z, Chouraqui P, Burstein M, eta!. 
Limited clinical value of exercise stress test for the screening of coronary artery 
disease in young, asymptomatic adult men. Am J Cardiol. 2000;86:462-4. [PMID: 
10946046] 
23. Davies B, Ashton WD, Rowlands DJ, El-Sayed M, Wallace PC, Duckett K, et 
a!. Association of conventional and exertional coronary heart disease risk factors 
in 5,000 apparently healthy men. Clin Cardiol. 1996;19:303-8. [PMID: 8706370] 
24. Sox HC Jr, Littenberg B, Garber AM. The role of exercise testing in screening 
for coronary artery disease. Ann Intern Med. 1989;110:456-69. [PMID: 2493211] 
25. Cameron JD, Jennings GL, Kay S, Wahi S, Bennett KE, Reid C, eta!. A self-
administered questionnaire for detection of unrecognised coronary heart disease. 
Aust N Z J Public Health. 1997;21 :545-7. [PMID: 9343902] 
26. Ekelund LG, Suchindran CM, McMahon RP, Heiss G, Leon AS, Romhilt 
DW, eta!. Coronary heart disease morbidity and mortality in 
hypercholesterolemic men predicted from an exercise test: the Lipid Research 
Clinics Coronary Primary Prevention Trial. JAm Col! Cardiol. 1989;14:556-63. 
[PMID: 2768706] 
27 
27. Caralis DG, Bailey I, Kennedy HL, Pitt B. Thallium-201 myocardial imaging 
in evaluation of asymptomatic individuals with ischaemic ST segment depression 
on exercise electrocardiogram. Br Heart J. 1979;42:562-7. [PMID: 518780] 
28. Pilote L, Pashkow F, Thomas JD, Snader CE, Harvey SA, Marwick TH, eta!. 
Clinical yield and cost of exercise treadmill testing to screen for coronary artery 
disease in asymptomatic adults. Am J Cardiol. 1998;81:219-24. [PMID: 9591907] 
29. Katzel LI, Sorkin JD, Goldberg AP. Exercise-induced silent myocardial 
ischemia and future cardiac events in healthy, sedentary, middle-aged and older 
men. JAm Geriatr Soc. 1999;47:923-9. [PMID: 10443851] 
30. Durm RL, Matzen RN, V anderBrug-Medendorp S. Screening for the detection 
of coronary artery disease by using the exercise tolerance test in a preventive 
medicine population. Am J Prev Med. 1991;7:255-62. [PMID: 1790029] 
31. Okin PM, Kligfield P, Milner MR, Goldstein SA, Lindsay J Jr. Heart rate 
adjustment of ST -segment depression for reduction of false positive 
electrocardiographic responses to exercise in asymptomatic men screened for 
coronary artery disease. Am J Cardiol. 1988;62:1043-7. [PMID: 3189166] 
32. Blumenthal RS, Becker DM, Moy TF, Coresh J, Wilder LB, Becker LC. 
Exercise thallium tomography predicts future clinically manifest coronary heart 
disease in a high-risk asymptomatic population. Circulation. 1996;93 :915-23. 
[PMID: 8598082] 
33. Gibbons LW, Mitchell TL, Wei M, Blair SN, Cooper KH. Maximal exercise 
test as a predictor of risk for mortality from coronary heart disease in 
asymptomatic men. Am J Cardiol. 2000;86:53-8. [PMID: I 0867092] 
28 
t 
L 
i 
34. Cole CR, Foody JM, Blackstone EH, Lauer MS. Heart rate recovery after 
submaximal exercise testing as a predictor of mortality in a cardiovascularly 
healthy cohort. Ann Intern Med. 2000;132:552-5. [PMID: 10744592] 
35. Ekelund LG, Haskell WL, Johnson JL, Whaley FS, Criqui MH, Sheps DS. 
Physical fitness as a predictor of cardiovascular mortality in asymptomatic North 
American men. The Lipid Research Clinics Mortality Follow-up Study. N Eng! J 
Med. 1988;319:1379-84. [PMID: 3185648] 
36. Giagnoni E, Secchi MB, Wu SC, Morabito A, Oltrona L, Mancarella S, eta!. 
Prognostic value of exercise EKG testing in asymptomatic normotensive subjects. 
A prospective matched study. N Eng! J Med. 1983 ;309:1085-9. [PMID: 
6621650] 
37. Stason WB, Fineberg HV. Implications of alternative strategies to diagnose 
coronary artery disease. Circulation. 1982;66:III80-6. [PMID: 6812982] 
38. Hollenberg M, Zoltick JM, Go M, Yaney SF, Daniels W, Davis RC Jr, eta!. 
Comparison of a quantitative treadmill exercise score with standard 
electrocardiographic criteria in screening asymptomatic young men for coronary 
artery disease. N Eng! J Med. 1985;313:600-6. [PMID: 4022047] 
39. Okin PM, Grandits G, Rautaharju PM, Prineas RJ, Cohen JD, Crow RS, eta!. 
Prognostic value of heart rate adjustment of exercise-induced ST segment 
depression in the multiple risk factor intervention trial. J Am Coli Cardiol. 
1996;27:1437-43. [PMID: 8626955] 
29 
40. Okin PM, Anderson KM, Levy D, Kligfield P. Heart rate adjustment of 
exercise-induced ST segment depression. Improved risk stratification in the 
Framingham Offspring Study. Circulation. 1991;83:866-74. [PMID: 1999037] 
41. Gordon DJ, Ekelund LG, Karon JM, Probstfield JL, Rubenstein C, Sheffield 
LT, et al. Predictive value of the exercise tolerance test for mortality in North 
American men: the Lipid Research Clinics Mortality Follow-up Study. 
Circulation. 1986;74:252-61. [PMID: 3731417] 
42. MoraS, Redberg RF, Cui Y, Whiteman MK, Flaws JA, Sharrett AR, et al. 
Ability of exercise testing to predict cardiovascular and all-cause death in 
asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence 
study. JAMA. 2003;290:1600-7. [PMID: 14506119] 
43. Gulati M, Pandey DK, ArnsdorfMF, Lauderdale DS, Thisted RA, Wicklund 
RH, et al. Exercise capacity and the risk of death in women: the StJames Women 
Take Heart Project. Circulation. 2003;108:1554-9. [PMID: 12975254] 
44. Lauer MS, Okin PM, Larson MG, Evans JC, Levy D. Impaired heart rate 
response to graded exercise. Prognostic implications of chronotropic 
incompetence in the Framingham Heart Study. Circulation. 1996;93:1520-6. 
[PMID: 8608620] 
45. Jouven X, Ducimetiere P. Recovery of heart rate after exercise [Letter]. N 
Eng! J Med. 2000;342:662-3. [PMID: 10702064] 
46. Frolkis JP, Pothier CE, Blackstone EH, Lauer MS. Frequent ventricular 
ectopy after exercise as a predictor of death. N Eng! J Med. 2003;348:781-90. 
[PMID: 12606732] 
30 
47. Morshedi-Meibodi A, Larson MG, Levy D, O'Donnell CJ, Vasan RS. Heart 
rate recovery after treadmill exercise testing and risk of cardiovascular disease 
events (The Framingham Heart Study). Am J Cardiol. 2002;90:848-52. [PMID: 
12372572] 
48. Wei M, Kampert JB, Barlow CE, Nichaman MZ, Gibbons LW, Paffenbarger 
RS Jr, et al. Relationship between low cardiorespiratory fitness and mortality in 
normal-weight, overweight, and obese men. JAMA. 1999;282:1547-53. [PMID: 
10546694] 
49. Blair SN, Kampert JB, Kohl HW 3rd, Barlow CE, Macera CA, Paffenbarger 
RS Jr, eta!. Influences of cardiorespiratory fitness and other precursors on 
cardiovascular disease and all-cause mortality in men and women. JAMA. 
1996;276:205-10. [PMID: 8667564] 
50. Rautaharju PM, Prineas RJ, Eifler WJ, Furberg CD, Neaton JD, Crow RS, et 
a!. Prognostic value of exercise electrocardiogram in men at high risk of future 
coronary heart disease: Multiple Risk Factor Intervention Trial experience. J Am 
Coli Cardiol. 1986;8:1-10. [PMID: 3711503] 
51. Allen WH, Aronow WS, Goodman P, Stinson P. Five-year follow-up of 
maximal treadmill stress test in asymptomatic men and women. Circulation. 
1980;62:522-7. [PMID: 7398012] 
52. Aronow WS, Allen WH, De Cristofaro D, Ungermann S. Follow-up of mass 
screening for coronary risk factors in 1817 adults. Circulation. 1975;51 :1038-45. 
[PMID: 1132094] 
31 
53. Aronow WS, Allen WH, De Cristofaro D, Ungermann S, Wan MK, Chun 
GM, eta!. Mass screening for coronary risk factors in 2,524 asymptomatic adults. 
JAm Geriatr Soc. 1975;23:121-6. [PMID: 1112961] 
54. Cumming GR, Sannn J, Borysyk L, Kich L. Electrocardiographic changes 
during exercise in asymptomatic men: 3-year follow-up. Can Med Assoc J. 
1975;112:578-81. [PMID: 1116087] 
55. Elamin MS, Boyle R, Kardash MM, Smith DR, Stoker JB, Whitaker W, eta!. 
Accurate detection of coronary heart disease by new exercise test. Br Heart J. 
1982;48:311-20. [PMID: 6127094] 
56. Fadayomi MO, Akinroye KK. Implications of positive treadmill exercise tests 
in asymptomatic adult African blacks. Eur Heart J. 1987;8:611-7. [PMID: 
3622541] 
57. Froelicher VF Jr, Thomas MM, Pillow C, Lancaster MC. Epidemiologic study 
of asymptomatic men screened by maximal treadmill testing for latent coronary 
artery disease. Am J Cardiol. 1974;34:770-6. [PMID: 4432807] 
58. Froelicher VF Jr, Thompson AJ, Wolthuis R, Fuchs R, Balusek R, Longo MR 
Jr, eta!. Angiographic findings in asymptomatic aircrewmen with 
electrocardiographic abnormalities. Am J Cardiol. 1977;39:32-8. [PMID: 831426] 
59. Gerson MC, Khoury JC, Hertzberg VS, Fischer EE, Scott RC. Prediction of 
coronary artery disease in a population of insulin-requiring diabetic patients: 
results of an 8-year follow-up study. Am Heart J. 1988;116:820-6. [PMID: 
3414496] 
32 
60. Gianrossi R, Detrano R, Mulvihill D, Lehmann K, Dubach P, Colombo A, et 
a!. Exercise-induced ST depression in the diagnosis of coronary artery disease. A 
meta-analysis. Circulation. 1989;80:87-98. [PMID: 2661056] 
61. Goodman S, Rubler S, Bryk H, Sklar B, Glasser L. Arm exercise testing with 
myocardial scintigraphy in asymptomatic patients with peripheral vascular 
disease. Chest. 1989;95:740-6. [PMID: 2924603] 
62. Gupta R, Gupta S. Value of maximal treadmill exercise test to screen 
asymptomatic persons for coronary artery disease. J Assoc Physicians India. 
1983;31:783-5. [PMID: 6674303] 
63. Hopkirk JA, Uhl GS, Hickman JR Jr, Fischer J, Medina A. Discriminant value 
.. 
of clinical and exercise variables in detecting significant coronary artery disease 
' in asymptomatic men. JAm Col! Cardiol. 1984;3:887-94. [PMID: 6707355] 
64. Macintyre NR, Kunkler JR, Mitchell RE, Oberman A, Graybiel A. Eight-year 
follow-up of exercise electrocardiograms in healthy, middle-aged aviators. Aviat 
f 
Space Environ Med. 1981;52:256-9. [PMID: 7283898] 
65. Manca C, Barilli AL, Dei Cas L, Bernardini B, Bolognesi R, Visioli 0. 
Multivariate analysis of exercise ST depression and coronary risk factors in 
asymptomatic men. Eur Heart J. 1982;3:2-8. [PMID: 7075608] 
66. Gibson RS. Comparative analysis of the diagnostic and prognostic value of 
exercise ECG and thallium-201 scintigraphic markers of myocardial ischemia in 
asymptomatic and symptomatic patients. Cardiol Clin. 1989;7:565-75. [PMID: 
2670227] 
33 
67. McHenry PL, O'Donnell J, Morris SN, Jordan JJ. The abnormal exercise 
electrocardiogram in apparently healthy men: a predictor of angina pectoris as an 
initial coronary event during long-term follow-up. Circulation. 1984;70:547-51. 
[PMID: 6478560] 
68. Melin JA, Piret LJ, Vanbutsele RJ, Rousseau MF, Cosyns J, Brasseur LA, et 
a!. Diagnostic value of exercise electrocardiography and thallium myocardial 
scintigraphy in patients without previous myocardial infarction: a Bayesian 
approach. Circulation. 1981 ;63:1019-24. [PMID: 7471359] 
69. Pedersen F, Sandoe E, Laerkeborg A. Prevalence and significance of an 
abnormal exercise ECG in asymptomatic males. Outcome of thallium myocardial 
scintigraphy. Eur Heart J. 1991;12:766-9. [PMID: 1889440] 
70. Roger VL, Jacobsen SJ, Pellikka PA, Miller TD, Bailey KR, Gersh BJ. 
Prognostic value of treadmill exercise testing: a population-based study in 
Olmsted County, Minnesota. Circulation. 1998;98:2836-41. [PMID: 9860784] 
71. Rubler S, Gerber D, Reitano J, Chokshi V, Fisher VJ. Predictive value of 
clinical and exercise variables for detection of coronary artery disease in men with 
diabetes mellitus. Am J Cardiol. 1987;59:1310-3. [PMID: 3591685] 
72. Selvester RH, Ahmed J, Tolan GD. Asymptomatic coronary artery disease 
detection: update 1996. A screening protocol using 16-lead high-resolution ECG, 
ultrafast CT, exercise testing, and radionuclear imaging. J Electrocardiol. 1996;29 
Suppl:135-44. [PMID: 9238390] 
73. Tubau JF, Szlachcic J, Hollenberg M, Massie BM. Usefulness ofthallium-201 
scintigraphy in predicting the development of angina pectoris in hypertensive 
34 
patients with left ventricular hypertrophy. Am J Cardiol. 1989;64:45-9. [PMID: 
2525866] 
74. Uhl GS, Kay TN, Hickman JR Jr. Computer-enhanced thallium scintigrams in 
asymptomatic men with abnormal exercise tests. Am J Cardiol. 1981;48:1037-43. 
[PMID: 6975560] 
75. Koistinen MJ, Huikuri HV, Pirttiaho H, Linnaluoto MK, Takkunen JT. 
Evaluation of exercise electrocardiography and thallium tomographic imaging in 
detecting asymptomatic coronary artery disease in diabetic patients. Br Heart J. 
1990;63:7-11. [PMID: 2310651] 
76. Salzmann P, Kerlikowske K, Phillips K. Cost-effectiveness of extending 
screening mammography guidelines to include women 40 to 49 years of age. Ann 
IntemMed. 1997;127:955-65. [PMID: 9412300] 
77. Conti CR, Bourassa MG, Chaitman BR, Geller NL, Knatterud GL, Pepine CJ, 
et al. Asymptomatic cardiac ischemia pilot (ACIP). Trans Am Clin Climatol 
Assoc. 1994;106:77-83. [PMID: 7483181] 
78. Coplan NL, Fuster V. Limitations ofthe exercise test as a screen for acute 
cardiac events in asymptomatic patients. Am Heart J. 1990;119:987-90. [PMID: 
2321524] 
79. Ashley EA, Myers J, Froelicher V. Exercise testing in clinical medicine. 
Lancet. 2000;356:1592-7. [PMID: 11075788] 
80. Bashore TM, Bates ER, Berger PB, Clark DA, Cusma JT, Dehmer GJ, et a!. 
American College of Cardiology/Society for Cardiac Angiography and 
Interventions Clinical Expert Consensus Document on cardiac catheterization 
laboratory standards. A report of the American College of Cardiology Task Force 
35 
on Clinical Expert Consensus Documents. JAm Coli Cardiol. 2001;37:2170-214. 
[PMID: 11419904] 
36 
I 
Table 1. Excluded Studies and Reasons for Exclusions 
Author and Year 
Allen et al., 1980 (51) 
Aronow et al., 1975 (52;53) 
Cumming et al., 1975 (54) 
Elamin et al., 1982 (55) 
Fadayomi et al., 1987 (56) 
Froelicher et al., 1974 (57) 
Froelicher et al., 1977 (58) 
Gerson et al., 1988 (59) 
Gianrossi et al., 1989 (60) 
Goodman etal., 1989 (61) 
Gupta et al., 1983 (62) 
Hopkirk et al., 1984 (63) 
Macintyre et al., 1981 (64) 
Manca et al., 1982 (65) 
Mark et al., 1989 (66) 
McHenry et al., 1984 (67) 
Melin et al., 1981 (68) 
Pedersen et al., 1991 (69) 
Roger et al., 1998 (70) 
Rubler et al., 1987 (71) 
Selvester et al., 1996 (72) 
Tubau et al., 1989 (73) 
Uhl et al., 1981 (74) 
Reason for Exclusion 
No adjustment of the relative risk of abnormal exercise 
tolerance testing for the effect of other risk factors 
No adjustment of the relative risk of abnormal exercise 
tolerance testing for the effect of other risk factors 
No adjustment of the relative risk of abnormal exercise 
tolerance testing for the effect of other risk factors 
Diagnostic usage - symptomatic patients 
Unclear ascertainment of endpoints 
No adjustment of the relative risk of abnormal exercise 
tolerance testing for the effect of other risk factors 
Did not report the total number of persons screened 
Did not report the independent risk of a positive exercise 
tolerance testing 
Diagnostic usage- symptomatic patients 
Subjects had previous history of cardiovascular disease 
Did not report the independent risk of a positive exercise 
tolerance testing 
Did not report the total number of persons screened 
No adjustment of the relative risk of abnormal exercise 
tolerance testing for the effect of other risk factors 
Did not report the independent risk of a positive exercise 
tolerance testing 
Subjects had previous history of cardiovascular disease 
No adjustment of the relative risk of abnormal exercise 
tolerance testing for the effect of other risk factors 
Diagnostic usage- symptomatic patients 
No adjustment of the relative risk of abnormal exercise 
tolerance testing for the effect of other risk factors 
Included symptomatic patients without sub-analysis 
No adjustment of the relative risk of abnormal exercise 
tolerance testing for the effect of other risk factors 
Used a screening protocol that employed multiple 
technolo ies 
No adjustment of the relative risk of abnormal exercise 
tolerance testing for the effect of other risk factors 
Did not report the total number of persons screened 
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Table 2. Studies of the Use of Exercise Electrocardiogram to Detect 
Asymptomatic Prevalent Coronary Heart Disease* 
Author and 
Year 
Caralis et 
al., 1979 
(27) 
Piepgrass 
et al., 1982 
(16) 
Hollenberg 
et al., 1985 
(38) 
Boyle et al., 
1987 (14) 
Stud~ Population 
3,496 men and 
women 
Mean age: NR 
%male NR 
771 men in United 
States Air Force 
flight crew 
Mean age: (SO): 42 
(5.2) 
100% male 
377 army officers 
Mean age 37 
%male NR 
1,174 employees 
from 2 factories in 
the U.K. 
Mean age: NR 
Age range: 19-64 
95% male 
Exclusion 
Criterion 
NR 
Rest EGG 
abnormalities, 
history of chest 
pain, CVD, 
marked HTN 
Known CHD 
Test Technique 
Maximal and 
thallium 
scintigram 
Maximal 
treadmill or 
Two-step 
Double 
Master's 
Maximal 
treadmiii-
USAFSAM 
Protocol 
Symptoms of Treadmill 
angina, 
orthopedic 
problems, 
hypertension 
with 
retinopathy, 
fainting and afib 
Definition of 
Abnormal 
Exercise ECG 
2:2 mm of 
horizontal ST 
depression 
2:0.1 mV of ST 
depression 80 
ms from the J 
point or 
exercise 
induced 
arrhythmia 
2:1 mm ST 
depression 
during or after 
exercise 
or 
treadmill 
exercise score 
< 5 units 
Maximal 
ST/HR slope 
value of >13 
mm·beats"1 
min 10·3 
* CABG, Coronary artery bypass graph surgery; CAD, Coronary artery disease; CHD, Coronary 
heart disease; CP, chest pain; CVD, Cardiovascular disease; DM, Diabetes mellitus; ECG, 
Electrocardiogram; ETT, Exercise tolerance test (treadmill); HTN, hypertension; J, Joules; mV, 
Millivolt; NR, Not reported; SD, Standard Deviation; VAMC, Veterans' Administration Medical 
Center; VD, vessel disease 
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Table 2. 
Preval 
ence of 
Abnor 
mal 
ETT 
22/349 
6 
(0.6%) 
271771 
(3.5%) 
45/377 
(12%) 
3/377 
(0.7%) 
68/1,17 
4 
(5.8%) 
Studies of the Use of Exercise Electrocardiogram to Detect 
Asymptomatic Prevalent Coronary Heart Disease (continued) 
Definition of 
Abnormal 
Cardiac 
Catheterizatio 
n 
NR 
NR 
;,sO% narrowing 
of the luminal 
diameter of 
major epicardial 
artery 
;,75% stenosis 
of epicardial 
artery 
Abnormal 
Catheteri-
zations/ Total 
Catheteri-
zations* 
!%! 
10/15 
(66.7%) 
4/19 
(21%) 
1/10 
(10%) 
9/24 
(37.5%) 
39 
Abnormal 
Catheteri-
zations/ 
Abnormal 
ETT* 
(%) 
10/22 
(45.5%) 
4/27 
(14.8%) 
1/45 
(2%) 
1/3 
9/68 
(13.2%) 
Abnormal ETT 
and Abnormal 
Catheterizations 
I Total Screened 
Population* 
(%) 
10/3,496 
(0.3%) 
4/771 
(0.5%) 
all cases were 
mild to moderate 
disease 
1/377 
(0.3%) 
1 had 1-VD 
9/1,174 
(0 8%) 
1 had CABG 
Quality 
Gradina 
Fair 
Fair 
Fair 
Fair 
Table 2. Studies of the Use of Exercise Electrocardiogram to Detect 
Asymptomatic Prevalent Coronary Heart Disease (continued) 
Author 
and Year 
Okin et 
al., 1988 
(31) 
Koistinen 
1990 
(15;75) 
Dunn et 
al., 1991 
(30) 
Study Population 
606 men in the 
Army Reserve at 
moderate to high 
risk by Framingham 
Risk score 
Mean age: NR 
Age: >40 years 
100% male 
136 diabetics in 
Finland 
Mean age: 48 
62% male 
1,930 patients 
referred to 
Cleveland Clinic 
Foundation for 
screening ETT in 
1987-88(5.6% had 
history of chest 
pain) 
Mean age: 49 
85% male 
40 
Exclusion 
Criterion 
Known or 
suspected CHD 
or angina 
Clinical 
evidence of 
CHD, lipid 
lowering agents, 
DM less than 
5 y, retinopathy 
and renal failure 
Known CAD 
Test Technique 
Modified Balke-
Warewith 
radionuclide 
scintigram for an 
abnormal 
exercise ECG 
Maximal bicycle 
ergometry and 
thallium 
scintigram 
Symptom-
limited exercise 
ECG, then 
thallium 
scintogram if 
exercise ECG 
abnormal 
Definition of 
Abnormal 
Exercise ECG 
<:1 mm ST 
depression 
<:1 mm 
horizontal or 
downsloping ST 
depression 
<:1 mm of 
horizontal or 
downsloping s-
depression or 
arrhythmia 
Table 2. 
Prevalen 
ce of 
Abnorm 
al ETT 
10/606 
(positive-
abnormal 
exercise 
EGG and 
scintigram 
) 
(inconclu-
sive-
abnormal 
exercise 
EGG and 
normal 
scintigram 
) 
52/606 
40/136 
(29%) 
155/1,93 
0 (8%) 
Studies of the Use of Exercise Electrocardiogram to Detect 
Asymptomatic Prevalent Coronary Heart Disease (continued) 
Definition of 
Abnormal 
Cardiac 
Catheterizatio 
n 
<!50% narrowing 
of the luminal 
diameter 
Significant 
<!50% narrowing 
of the luminal 
diameter 
<!50% blockage 
of any major 
vessel 
Abnormal 
Catheteri-
zations/ Total 
Catheteri-
zations* 
(%! 
7/10 
(70%) 
12/34 
(35%) 
CAD 25/41 
(61%) 
41 
Abnormal 
Catheteri-
zations/ 
Abnormal 
ETT* 
!"/o! 
7/10 
(70%) 
12/40 
(30%) 
25/155 
(16.1%) 
Abnormal ETT 
and Abnormal 
Catheterizations 
I Total Screened 
Population* 
!%) 
7/606 
(1.2%) 
2 had 3-VD, 
2 had 2-VD, 
3 had 1-VD 
12/136 
(9%) 
5 had 1VD 
5-had 2 VD 
2-had 3 VD 
25/1,930 
(1.3%) 
6 had CABG 
Quality 
Ratina 
Good 
~ 
~ 
I! 
I 
t 
Fair 
Fair 
Table 2. Studies of the Use of Exercise Electrocardiogram to Detect 
Asymptomatic Prevalent Coronary Heart Disease (continued) 
Definition of 
Author and Exclusion Test Abnormal 
Year Stud:z: Population Criterion Technique Exercise ECG 
Massie et 226 men from the Known cardiac Standard Bruce <:0.1 mV of 
al., 1993 San Francisco disease history with thallium additional 
(18) VAMC-all had or symptoms, scintigraphy horizontal or 
hypertension and at rest EGG downsloping s· 
least 1 other abnormalities, segment 
cardiovascular risk paced rhythm, depression at 
factor noncardiac 80 ms after the 
limitation to J point. 
Mean age (SD): 61 exercise 
(8) 
100% male 
Davies et 5,000 men from the NR Modified Balke 1 mVof 
al., 1996 United Kingdom horizontal or 
(23) downsloping 
Mean age: NR depression 
persisting for <=! 
100% male complexes 
Cameron et 229 Australians Known CAD or Modified Bruce Flat ST 
al., 1997 responding to negative segment 
(25) questionnaire about screening depression 
chest pain questionnaire <=0.15mV 
Mean age: NR 
43% male 
Pilote et al., 4,334 patients History of chest Bruce or <=1 mm 
1998 (28) referred to pain, heart modified Bruce horizontal or 
Cleveland Clinic failure, valvular downsloping s· 
Foundation for or congenital depression, <:1 
screening ETT heart disease, mmST 
19901993 arrhythmia or elevation in 
digitalis use leads other 
Median age: 51 than aVR or V1 
drop in BP <: 1C 
89% male mmHg, typical 
CP, failure to 
reach target 
heart rate 
42 
Table 2. Studies of the Use of Exercise Electrocardiogram to Detect 
Asymptomatic Prevalent Coronary Heart Disease (continued) 
Abnormal Abnormal Abnormal ETT 
Prevale Definition of Catheteri- Catheteri- and Abnormal 
nee of Abnormal zations/ Total zations/ Catheterizations 
Abner Cardiac Catheteri- Abnormal I Total Screened 
mal Catheterizatio zations* ETT* Population* 
ETT n (%) (%} (%) 
Abnorm Intraluminal Abnormal Abnormal 20/226 Fair 
al lesion of <:50% exercise ECG exercise (9%) 
exercise diameter of 14/26 14/67 
ECG vessel in 2 (54%) (21%) 
67/226 projections 6 had left main 
(30%) disease or 3-VD; 
5 had 2-VD; 
7 had 1-VD 
Abnorm Abnormal Abnormal 
al scintigram scintigram 
scintigra 18/21 18/29 
m (86%) (62%) 
41/226 
(18%) 
162/5,0 <:75% stenosis 67/86 67/162 67/5,000 Fair 
00 epicardial artery (78%) (41.4%) (1.3%) 
(3.2%) 
26 had CABG 
Males NR 10/13 10/32 10/229 Fair 
15/98 (77%) (31%) (4%) 
(15.3%) 
Female 4 had CABG 
s 
17/131 
(13%) 
633/4,3 CAD <:1 71/126 71/633 71/4,334 Poor 
34 coronary (56%) (11%) (1.6%) 
(15%) segment with 
<:50% stenosis 
43 
Severe CAD-
left main 
disease with 
<=50% stenosis 
or 3 vessel 
disease with 
<: 70% stenosis 
or proximal 
LAD and 2V 
with <=70% 
stenosis 
19/126 
(15%) 
44 
19/633 
{3%) 
19/4,334 
(0.4%) 
Fair 
Table 2. Studies of the Use of Exercise Electrocardiogram to Detect 
Asymptomatic Prevalent Coronary Heart Disease (continued) 
Definition of 
Author and Exclusion Test Abnormal 
Year Study Population Criterion Technique Exercise ECG 
Livsch itz et 4,900 male soldiers Angina, heart Bruce <:1 mV of 
a!., 2000 in the Israeli army failure, valvular horizontal or 
(22) <:39 years of age disease, downsloping s-
congenital heart depression or 
Mean age (SO): disease, or <:1.5 mV 
43(3) arrhythmia upsloping ST 
depression 
100% male 
Blumenthal 734 primarily white Known CAD, Modified Bruce NR for ETT 
eta!., 2003 healthy siblings of limitations that and thallium 
(17) individuals precluded scintigraphy 
diagnosed with testing 
CAD before age 60 
in Baltimore 
Mean age: NR 
Age: < 60 years 
"Primarily male" 
45 
Table 2. 
Prevalen 
ce of 
Abnorma 
I ETT 
299/4,900 
(6.1%) 
153/734 
(21%) 
(Abnormal 
exercise 
ECG, 
scan, or 
both) 
Studies of the Use of Exercise Electrocardiogram to Detect 
Asymptomatic Prevalent Coronary Heart Disease (continued) 
Definition of 
Abnormal 
Cardiac 
Catheterization 
NR 
Significant CAD 
intraluminal lesion 
of ;e50% diameter 
Hemodynamically 
significant CAD 
intraluminal lesion 
of;, 70% diameter 
Abnormal 
Catheteri-
zations/ Total 
Catheteri-
zations* 
(%) 
3/4 
(75%) 
41/105 (39%) 
24/105 
(23%) 
Abnormal 
Catheteri-
zations/ 
Abnormal 
ETT* 
(%) 
3/299 
(1%) 
41/153 
(27%) 
24/153 
(16%) 
Abnormal ETT and 
Abnormal 
Catheterizations/ Total 
Screened Population* 
(%) 
3/4900 
(0.06%) 
1 had CABG 
2 had 1-VD 
41/734 
(5.5%) 
24/734 
(3.3%) 
*Percentages were calculated by the authors ofthis report. 
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Table3. Association between Abnormal ST Segment Response to 
Exercise and Coronary Heart Disease Events in 
Asymptomatic Individuals§ 
Mean 
Years 
Author of Abnormal Test 
and Study 
Year Population Exclusion 
Giagn 514 factory Positive 
oni et workers in Italy history and PE 
al., for CVD, rest 
1983 Age range: 18- BP <o160/95, 
(36) 65 abnormal rest 
EGG 
73% male 
MRFI 6,205 MRFIT Clinical heart 
TTrial (multi-center disease, life-
Resea cohort study - limiting 
rch men in the upper conditions, 
Group 10% to 15% DBP <o115, 
' 
Framingham risk cholesterol 
1985( score distribution) <o350 
8) 
Age range: 35-57 
Rauta 
harju 100% male 
et al., 
1986 
(50) 
Gordo 3,640 white men Evidence of 
net al., in Lipid Research CHD based on 
1986 Clinics history, rest 
(41) Prevalence EGG, and 
Survey in US and physician 
Ekelu Canada exam. 
nd et Secondary 
al., Mean age: 47 HLP, BMI 
1989 >32.1, BP 
(26) Age range: 35-59 <o165/105. on 
anti-HTN or 
100% male CVmed, DM 
* Events are CHD events unless otherwise indicated. 
t CHD death. 
t All cause death 
Follow 
-up Technique Definition 
6 Submaximal <o1 mm of 
supine cycle horizontal! 
ergometry downsloping 
ST depress 
during or 
after 
exercise 
7 Submaximal Computer 
code-ST seg 
depression 
16 ~V-s or 
more in 
leads CS5, 
aVL, aVF, 
V5 during or 
after 
exercise (in 
EGG with 
less than 
6~V-s 
depress at 
rest) 
8.1 Submaximal <o1 mm of 
Modified ST depress 
Bruce or elevation/ 
computer-
ST integral 
decreased 
or increased 
<o10 ~V-s 
from rest 
value 
§AS, Aortic stenosis; aVL, Name ofECG lead; BMI, Body mass index; BP, Blood pressure; 
CAD, Coronary artery disease; CHD, Coronary heart disease; Chol, Cholesterol; CP, Chest pain; 
CV, Cardiovascular; CVD, Cardiovascular disease; DBP, Diastolic blood pressure; DM, Diabetes 
mellitus; ECG, Electrocardiogram; ETT, Exercise tolerance test); FBG, fasting blood glucose; 
HDL, High-density lipoprotein cholesterol; HR, Heart rate; HTN, Hypertension; LBBB, Left 
bundle branch block; LDL, Low-density lipoprotein cholesterol; MC, Minnesota Code; MRFIT, 
47 
Prevalenc 
e 
NR 
12.2% 
8.3% 
Multiple Risk Factor Intervention Trial Research Group; NR, Not reported; PVC, Premature 
ventricular comples; RBBB, Right bundle branch block; SBP, Systolic block pressure; SVT, 
Supraventricular tachycardia; V02, oxygen consumption; VT, Ventricular tachycardia 
48 
Table3. Association between Abnormal ST Segment Response to 
Exercise and Coronary Heart Disease Events in 
Asymptomatic Individuals (continued) 
Cumulative 
Event Rate* 
Normal ETT 
3.4% 
Abnormal 
ETT 15.6%t 
Normal ETT 
211,000 
person yearst 
Abnormal ETT 
7.611,000 
person yearst 
Placebo group 
Normal ETT 
1311,000 
person yearst 
Abnormal ETT 
1.911,000 
person yearst 
Cholestyramine 
group 
Normal ETT 
7.211,000 
person yearst 
Abnormal ETT 
1.511,000 
person earst 
Adjusted Relative 
Risk for CHD 
Events with 
Abnormal ST 
Segment 
Response 
5.5 
(2.8-11.2) 
3.5 
(P <0.05) t 
1.61 
(P <0.01):j: 
Placebo group 
5.7 
(2.7-12.2) t 
3.3 
(1.8-5.9) :j: 
Cholestyramine 
group 
4.9 
(2.2-10.8)t 
2.9 
(1 6-5.2) :j: 
49 
Sensitivity for 
CHD Events 
62 
Not reported 
30 
Positive 
Predictive Value 
of Abnormal ST 
Response 
15 
36 
7.1 
Relative Risk 
Adjusted for 
the Following 
Variables 
Age, SBP, 
smoking, 
coronary risk 
index 
Age, DBP, 
cholesterol, 
number of 
cigarettes 
smoked daily 
Age, LDL, HDL, 
SBP, smoking, 
family history 
\-
k 
' 
' 
Table3. Association between Abnormal ST Segment Response to 
Exercise and Coronary Heart Disease Events in 
Asymptomatic Individuals (continued) L 
Mean 
Years Abnormal Test 
of 
Author and Study Follow-
Year Population Exclusion U(! Technique Definition Prevalem 
Fleg et al., 407 residents NR 4.6 Maximal <o1 mm of 
1990 (19) of Baltimore, treadmill with horizontal/ 
Maryland Thallium downsloping Abnormal 
(mainly white) Modified during or EGG only 
Balke after 16.0% 
Mean age exercise 
(SD): 60 (11) 
Abnormal 
Age range: 40- Thallium 
b 90 only 14% 
71% male 
Both test! 
abnormal ~ 6.0% Okin et al., 3,168 Medical 4.3 Standard ST segment 416/3168 .. 
1991 (40) participants in contraindicati Bruce corrected 13% ~ 
~ 
the ens to for heart ;; r 
Framingham exercise, rate index (either tes 
Offspring history of >1.6 abnormal; 
Study myocardial ~V/beats/ 
infarction, min 
Mean age CHF, valvular 
(SD): 44 (10) disease, or 
Age range: syncope, 
. 
17-70 conduction abnormal 
abnormalities, rate 
48% male digoxin use, recovery 
atrial loop 
fibrillation 
Siscovick et 3,617 white Clinical 7.4 Modified Visual code 6.6% 
al., 1991 (12) men in the evidence of Bruce - <o1 mm ST 
Lipid CHD orCHF Submaximal depression 
Research on history, or elevation 
Clinics various rest or 
Prevalence EGG Computer 
Survey abnormalities code- <o10 ~ ~V/sec 
Mean age: NR 
Age range: 
35-59 
100% male 
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Table3. Association between Abnormal ST Segment Response to 
Exercise and Coronary Heart Disease Events in 
Asymptomatic Individuals (continued) 
Cumulative 
Event Rate• 
Both 
normal?% 
Abnormal 
ECG only 
12% 
Abnormal 
Thallium 
only 3% 
Both tests 
abnormal 
48% 
Both normal 
1.6% 
Either test 
abnormal 
4.1% 
Both tests 
abnormal 
9.8% 
Overall2% 
(for CHD 
events 
occurring 
during 
exercise) 
Adjusted 
Relative Risk 
for CHD Events 
with Abnormal 
STSegment 
Response 
1 
2.4 
(P < 0.05) 
1.4 
(NS) 
3.6 
(1.6-8.1) 
1 
1.6 
(1.1-2.5) 
2.7 
(1.8-4 0) 
2.6 
(1.3- 5.2) 
(for CHD events 
occurring during 
exercise) 
Positive 
Predictive 
Value of 
Sensitivity for Abnormal ST 
CHD Events Response 
40 24 
N/A N/A 
28 48 
23% 4% 
8% 10% 
18% 5% 
51 
Relative Risk 
Adjusted for the 
Following Variables 
Age, sex, HTN, FBG, 
total cholesterol, 
BMI, smoking, 
exercise duration 
Age, sex, smoking, 
DBP, total 
cholesterol, FBG, 
LVH on ECG 
Age, LDL, HDL, 
smoking, physical 
activity, workload 
achieved, family 
history of CHD, BMI, 
alcohol consumption 
52 
Table3. Association between Abnormal ST Segment Response to 
Exercise and Coronary Heart Disease Events in 
Asymptomatic Individuals (continued) 
Cumulative Event 
Rate* 
Normal3% 
+exercise EGG 7% 
+scan 13% 
+exercise EGG and 
scan 50% 
Normal ETT 1.3%t 
Abnormal 
5.4%t 
Overall18% 
Adjusted 
Relative Risk 
for CHD Events 
with Abnormal 
STSegment 
Response 
1 
1.5 
(0.2-12.5) 
3.6 
(1.1-11.4) 
14.5 
(4.2-50.2) 
3.6 
(2.4-5.4)t 
4.23 
(2.03-8.83) 
Sensitivity for 
CHD Events 
N/A 
63% 
32% 
36% 
55% 
53 
Positive 
Predictive 
Value of 
Abnormal ST 
Response 
N/A 
20% 
50% 
5% 
46% 
Relative Risk 
Adjusted for 
the Following 
Variables 
Age, sex 
Age. DBP, chol, 
smoking 
age, BMI, 
maximal V02, 
fasting glucose 
Table3. Association between Abnormal ST Segment Response to 
Exercise and Coronary Heart Disease Events in 
Asymptomatic Individuals (continued) 
Mean 
Years 
of 
Follow-
Abnormal Test 
Author 
and Year 
Gibbons 
et al., 
2000 (33) 
Study Population 
25,927 patients of a 
preventive medicine 
clinic in Texas (mainly 
white) 
Mean age: 42.9 
Age range 20-82 
100% male 
Exclusion 
Evident CHD, 
severe AS, 
acute systemic 
illness, 
uncontrolled 
atrial or 
ventricular 
arrhythmias, 
pericarditis, 
myocarditis, 
thrombophlebitis 
or exercise 
limiting 
orthopedic 
problems 
54 
up 
8.4 
Technique 
Maximal 
treadmill 
Modified 
Blake 
Definition 
CP and<: 
1mmST 
segment 
depression 
or elevation 
also 
exercise 
induced-
dec <=10mm 
in SBP, 
SBP >250, 
DBP >1 20, 
VT, LBBB, 
RBBB,SVT 
Prevalenc 
e 
No risk 
factors, 
3.0% 
>1 risk 
factor, 
7.1% 
,_ __ 
L 
L 
I 
Table3. Association between Abnormal ST Segment Response to 
Exercise and Coronary Heart Disease Events in 
Asymptomatic Individuals (continued) 
Cumulative Event 
Rate 
No risk factor 
Normal ETT 
0.08/1000 person 
yearst 
Abnormal ETT 
2.8/1000 person 
earst 
>1 risk factor 
Normal ETT 
0.5/1000 person 
yearst 
Abnormal ETT 
7. 6/1 000 person 
yearst 
Adjusted 
Relative Risk 
for CHD Events 
with Abnormal 
ST Segment 
Response 
21 
(6.9-63.3)t 
9t 
Sensitivity for 
CHD Events 
60 
61 
55 
Positive 
Predictive 
Value of 
Abnormal ST 
Response 
2.2 
7.7 
Relative Risk 
Adjusted for the 
Following 
Variables 
Age 
I 
Table3. Association between Abnormal ST Segment Response to 
Exercise and Coronary Heart Disease Events in 
Asymptomatic Individuals (continued) 
Author 
and Year Study Population Exclusion 
Josephson et 1, 083 History of 
al., 1990 (11) participants in angina or 
the Baltimore heart failure, Q 
Rywik et al., Longitudinal wave on rest 
2002 (21) Study of Aging EGG, valvular 
Mean age (SD): 
52(18) 
57% male 
disease, use 
of anti-
arrhythmic 
drugs, those 
who did not 
achieve 85% 
of max heart 
rate 
56 
7.9 
Mean 
Years 
of 
Follow-
Abnormal Test 
up Technique Definition Prevalence 
Modified Balke Normal 
MC 11.1-<=1 20% 
mm J point 
depression 
with flat or 
downsloping 
ST segment in 
most 
complexes in 
any lead 
except aVR 
MC 11.5 ST 5.5% 
depression at 
rest that 
worsens to 
MC11.1 during 
exercise 
MC 11.2-
Horizontal or 
downsloping 
ST depression 
of 0.5-1.0 mm 
MC 11.4-J 
7% 
11.5% 
l---
L 
L ,... 
' 
I 
Table3. Association between Abnormal ST Segment Response to 
Exercise and Coronary Heart Disease Events in 
Asymptomatic Individuals (continued) 
Cumulative Event 
Rate* 
Adjusted 
Relative Risk 
for CHD Events 
with Abnormal 
ST Segment 
Response 
Sensitivity for 
CHD Events 
Positive 
Predictive 
Value of 
Abnormal ST 
Response 
Relative Risk 
Adjusted for 
the Following 
Variables 
Male4% 
Female 3% 
Male 17% 
FemaleS% 
Male 17% 
Female 11% 
Male 10% 
Female 5% 
Male 17% 
Female 3% 
1 
OR2.7 
(1.6-4.7) 
OR2.7 
(1.05-7.10) 
OR 1.8 
(0.6-5.4) 
OR 1.3 
(0.6-2.9) 
Male 74% 
Female68% 
57 
Male 16% 
Female 7% 
Age, cholesterol, 
sex, exercise 
duration 
l 
' L 
Table3 Association between Abnormal ST Segment Response to 
Exercise and Coronary Heart Disease Events in 
Asymptomatic Individuals (continued) 
Mean 
Years 
of 
Author and Study Follow-
Year Population Exclusion up Technique Abnormal Test 
Jouven and 6,101 Frenchmen in Known or 23 Bicycle J-point 4.4% 
Ducimetiere, Paris Civil Service suspected ergometry depression of 
2000 (45) CVD, at least 1 mm 
Age range: 42-53 SBP;,180 at with a flat or 
rest, rest downsloping 
100% male ECG ST segment 
abnormality during 
exercise or 
recovery 
Laukkanen et 1,769 study Known CHD 10 Maximal >1 mm ST 10.7 b 
a/, 2001 {20) participants, or symptoms Bicycle depression during % 
population in suggestive of ergometry exercise 
Kupio Ischemic CHD t Heart Disease 
' 
Study base 
sample of Finnish ~ men 
Mean age (SD): 
52 (5.2) 
100% male 
Rutter et a/, 86 diabetics in History of 2.8 treadmill > 1 mm of (52 
2002 (13) the U.K. CAD horizontal or %) 
downs/oping ST 
Mean age (SD): segment t-
62(7) depression for 3 i 
Age range: 46- consecutive 
74 beats 
72% male 
Mora eta/, 2994 women Pregnancy or 20.3 Maximal ;,1 mm horizontal 4.7 
2003(42) enrolled in the significant Bruce or downs/oping % 
Lipid Research cardiovascu/a protocol ST depression 
Clinics r disease at 0.08 seconds 
Prevalence after the J point 
Study during recovery . 
or exercise 
Age range 30-80 
0% male 
58 
Table3. Association between Abnormal ST Segment Response to 
Exercise and Coronary Heart Disease Events in 
Asymptomatic Individuals (continued) 
Cumulative Event 
Rate* 
Normal ETT 6.4% 
Abnormal ETI 
16.7%t 
Normal ETI 9.2% 
2.4%t 
Abnormal15.3% 
7.9%t 
Both normal and 
abnormal ETT 
17% 
Both normal and 
abnormal ETT 
5%t 
14%:j: 
Adjusted 
Relative Risk 
for CHD Events 
with Abnormal 
ST Segment 
Response 
2.6 
(1.93-3.59) t 
1.7 
(1.1-2.6) 
3.5 
(1.9-6.5) t 
21 
(2-204) 
0.88 
(0.48-161) t 
0.69 
(0.45-1.04) :j: 
Sensitivity for 
CHD Events 
10 
16 
100% 
59 
Positive 
Predictive 
Value of 
Abnormal ST 
Response 
17-25 
15 
20% 
Relative Risk 
Adjusted for the 
Following 
Variables 
Age, BMI, HR at 
rest, smoking, 
physical activity, 
DM, total chol, 
PVC 
Age, examination 
year, smoking, 
SBP, alcohol 
consumption, BMI, 
max oxygen 
uptake, DM, LDL, 
HDL 
Ankle brachial 
index, 
microalbuminuria, 
Framingham 1 0-y 
CHD risk >30%, 
fibrinogen 
Age, smoking, 
diabetes, family 
history of 
premature heart 
disease, obesity, 
HDL, LDL, 
triglycerides, 
hypertension 
L 
i 
r [ 
.L 
f 
' I 
T 
I 
; 
L 
l 
t 
Table4. Association between Exercise Predictors and Coronary Heart 
Mean 
Study Exclusion Years of Test Definition of 
Author Year Population Criteria Follow-up Technique Abnormal Test 
Ekelund et 3,1 06 (healthy Men with CVD 8.5 Modified Bruce HR during stage 2 
al., 1988 (35) group of white sx and/or HTN submaximal ofETiand 
men) in Lipid were analyzed exercise time 
Research separately 
Clinics 
Prevalence 
Survey in US 
and Canada 
Age range: 30-
69 
100% male 
Lauer et al., 1,575 subjects Prevalent 7.7 Bruce protocol Failure to achieve 
1996 (44) in Framingham CAD, inability submaximal age- and sex-
Offspring to reach stage predicted target 
Study 2 in Bruce heart rate on ETT 
(predominantly protocol, use 
white) of 13-blockers 
at time of ETI 
Mean age: 43 
100% male 
Disease Events in Asymptomatic Individuals§ 
* Events are CHD events unless otherwise indicated. 
t CHD death. 
t All cause death 
§ BMI, Body mass index; CAD, Coronary artery disease; CHD, Coronary heart disease; Chol, 
Cholesterol; COPD, Chronic obstructive pulmonary disease; CVD, Cardiovascular disease; DM, 
Diabetes mellitus; ECG, Electrocardiogram; ESRD, End-stage renal disease; ETT, Exercise 
tolerance test; HDL, High-density lipoprotein cholesterol; HR, Heart rate; HTN, Hypertension; 
LDL, Low-density lipoprotein cholesterol; METS, unit of metabolic work; PVC, Premature 
ventricular complex; PVD, Premature ventricular depolarizations (synonym to PVC); SBP, 
Systolic blood pressure; SD, Standard Deviation; SES, Socio-economic status; YEA, Ventricular 
ectopic arrhythmia; VFib, Ventricular fibrillation; VPC, Ventricular premature contractions; VT, 
Ventricular tachycardia 
60 
L 
L 
Prevalence 
of Predictor 
Increase of 2 
SO in stage 
2 HR 
Decrease of 
2 SO in time 
on the 
treadmill 
k 
' 
' 
21% 
L 
~ 
i 
I 
f 
Table 4. 
Cumulative 
Event Rate 
0.26-1.69%t 
3% for those 
who reached 
target heart rate 
(All cause 
death) 
6% for those 
who failed to 
reach heart 
rate:j: 
Association between Exercise Predictors and Coronary Heart 
Disease Events in Asymptomatic Individuals (continued) 
Relative Risk for CHD 
Events with Positive Test 
3.2 
(1.5-6.7) 
2.8 
(1.3-6.1) 
No significant association of 
predictor to all cause death 
1.75 
(1.11-2.74)t 
61 
Sensitivity 
forCHD 
Events 
NR 
46% 
Positive 
Predictive Value 
of Abnormal ST 
Response 
NR 
14% 
Relative Risk 
Adjusted for the 
Following 
Variables 
Age, smoking, 
HDL, LDL, SBP 
Age, ST segment 
response, 
physical activity, 
BMI, smoking, 
HTN,HTN 
medication, DM, 
total 
cholesteroi/HDL 
~-
L 
-L 
Table 4. Association between Exercise Predictors and Coronary Heart 
Disease Events in Asymptomatic Individuals (continued) 
Mean 
Years of 
Author Study Exclusion Follow- Definition of Prevalence 
Year Population Criteria up Test Technique Abnormal Test of Predictor 
Wei et al., 25,714 History of 24 Maximal Low fitness Normal 
1999 (48) patients at a cancer, treadmill using age-based weight: 10% 
preventive BMI < 18.5, METS cut points 
Blair et al., med clinic in age< 20 and on ETT 
1996 (49) Texas those with < 1 Overweight: 
Aerobics year of follow- 24% 
Center up 
Longitudinal Obese: 50% 
Study 
(>95% white), 
10% of men ~ with known 
CVD 
Mean age: ~ 43.8 
100% male I 
Cole et al., 5, 234 in Lipid Age< 30, use 12 Bruce or Abnormal HR 33% 
2000 (34) Research Clinics of ~-blockers, modified Bruce recovery defined 
Prevalence digoxin, submaximal as heart rate 
Survey in US antiarrhythmic change of42 
and Canada agents or beats/min or less 
nitrates, from peak 
Mean age: >30 history of exercise to that 
years cardiovascular measured 2 min L 
disease, later 
39% male unable to 
reach sta e2 
Jouven and 6, 101 Known or 23 Bicycle PVCs 2.3% 
Ducimetier Frenchmen in suspected ergometry constituting more 
2000 (45) Paris civil CVD,SBP than 1 0% of all 
service <!180 at rest, ventricular 
rest EGG depolarizations 
Age range: 42- abnormality during exercise 
53 
100% male 
' L 
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Table 4. 
Cumulative 
Event Rate 
Overall 
1.7/1,000 
person 
yearst 
Normal heart 
rate recovery 
4% death 
Abnormal 
heart rate 
recovery 1 0% 
death 
Normal ETT 
6.4% 
Abnormal 
ETT 16.1%t 
Association between Exercise Predictors and Coronary Heart 
Disease Events in Asymptomatic Individuals (continued) 
Positive Relative Risk 
Relative Risk for CHD Sensitivity Predictive Value Adjusted for the 
Events with Abnormal ST for CHD of Abnormal ST Following 
Segment Response Events Response Variables 
1.7 1.6 36% 4.6% DM, cholesterol, 
(1.1-2.5)t (1.3-2.1):j: HTN, current 
smoking, history 
1.9 1.7 52% 5.4% of CVO, abnormal 
(1.4-2.5)t (1.4-2.0):j: EGG at rest, age, 
BMI parental 
2.0 2.3 79% 3.4% history of CVO, 
(1.5-3.4)t (1.5-3.4):j: examination year 
1.95 54% 10% Age, sex, BMI, 
(1.11-3.42)t ethnicity, SBP, 
HTN medication, 
1.55 exercise habits, 
(1.22-1.98):j: physical fitness, 
smoking, OM, 
lipids, ST 
segment 
response, H R, 
chronotropic 
index, SES 
2.53 5%t 17%t Age, BMI, heart 
(1.65-3.88)t rate, SBP, 
tobacco, I eve I of 
physical activity, 
OM, total 
cholesterol, 
presence or 
absence of PVO 
before or after 
exercise 
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Table 4. Association between Exercise Predictors and Coronary Heart 
Disease Events in Asymptomatic Individuals (continued) 
Mean Years 
Author Study Exclusion of Follow- Test Definition of Preva-lence 
Year Po!!ulation criterion up Technique Abnormal Test of Predictor 
Morshedi- 2,967 Prevalent 15 Bruce Heart rate N/A 
Meibodi participants in CVD, COPD, submaximal recovery index 
et al., Framingham use of -decline in 
2002 (47) Off spring digoxin or ~- peak heart rate 
Study blockers, rest to time 2 
ECG minute of <42 
Mean age abnormali- beats per 
(SD): 43 (10) ties, inability minute 
to complete 
47% male stage 1 of 
exercise 
Rywik et 1,083 History of 7.9 Modified Balke Duration of NA 
al., 2002 participants in angina or HF, exercise 
(21) the Baltimore Q wave on rest 
Longitudinal ECG, valvular 
Study of Aging disease, use of 
antiarrhythmic 
Mean age (SD): drugs, those 
52(18) who did not 
achieve 85% 
57% male of max heart 
rate 
Frolkis et 29,244 persons Age <30, 5.3 Bruce Frequent VEA- NoVEA 
al., 2003 referred to symptomatic protocol ~7VPC's/ 
(46) Cleveland Clinic heart failure, submaximal minute, 
for ETT use of digoxin, ventricular 
valvular bigeminyor Freq VEA 
Mean age (SD): disease, trigeminy, during 
56 (11) ESRD, pacer, ventricular recovery 2% 
atrial fibrillation, couplets or 
70% male heart block, triplets, VT, Freq VEA 
freq VEA at ventricular during 
rest, heart flutter, torsade exercise 3% 
transplant, de pointes or 
concurrent VFib 
evaluation for 
an arrhythmia 
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Table 4. Association between Exercise Predictors and Coronary Heart 
Disease Events in Asymptomatic Individuals (continued) 
Positive Relative Risk ' 
Relative Risk for CHD Sensitivity Predictive Value Adjusted for 
Cumulative Events with Abnormal ST forCHD of Abnormal ST the Following 
Event Rate Segment Response Events Response Variables 
Overall 7.2% 1.1 NA NA Age, BMI, 
(0.8-1.5) smoking, 
SBP, DBP, 
0.8 anti-HTN 
(0.5-1.1) :j: medication, 
OM, total 
cholesterol, 
HDL, resting 
heart rate 
and peak 
heart rate 
Overall?% 0.87 NR NR Age, 
(0.79-0.96) cholesterol, ~ 
(For CHD event for 1 minute sex, ST 
increase in exercise segment 
duration) changes i 
~ 
I 
1 
5%:j: 1 Age, sex, DM, 
HTN, smoking, 
11%:j: Freq VEA during recovery 1.5 3% 12% prior CAD, 
(1.1-1.9):j: medication use, 
BMI, resting 
L 9%:j: Freq VEA during exercise 1.1 4% 9% heart rate SBP, 
(0.9-1.3):j: ST segment 
changes, 
chronotropic 
incompetence, 
abnormal heart 
rate recovery, 
peak exercise 
ca acit 
' i-
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Table 4. Association between Exercise Predictors and Coronary Heart 
Disease Events in Asymptomatic Individuals (continued) 
Author 
Year 
Mora et al., 
2003 
Gulati et 
al., 2003 
Exclusion 
Study Population criterion 
2994 women Pregnancy or 
enrolled in the significant 
Lipid Research cardiovascular 
Clinics Prevalence disease 
Study 
Age range 30-80 
0% male 
5721 women from 
the Chicago area 
(86% white) 
Mean age 52 
years 
0% male 
Self reported 
CHD, 
Percutaneous 
coronary 
intervention, 
coronary 
bypass surgery, 
congestive 
heart failure 
66 
Mean Years 
of Follow-
up 
20.3 
9 
Test 
Technique 
Maximal 
Bruce 
protocol 
Maximum 
Bruce 
protocol 
Definition of 
Abnormal Test 
Low exercise 
capacity(< 7.5 
METS) and low 
heart rate 
recovery (<55 
beats/minute) 
Exercise 
capacity in 
METS 
Prevalence 
of Predictor 
31% 
Table4. 
Cumulati 
ve Event 
Rate 
Both 
normal 
and 
abnormal 
ETT 
5%t 
14%:j: 
3.2%:j: 
Association between Exercise Predictors and Coronary Heart 
Disease Events in Asymptomatic Individuals (continued) 
Relative Risk for CHD 
Events with Abnormal ST 
Segment Response 
3.52t 
(1.57-7.86) 
2.11:j: 
(1.47-3.04) 
0.83 
(0. 78-0.89) 
for each 1 MET increase in 
exercise capacity 
67 
Sensitivity 
forCHD 
Events 
71% 
Positive 
Predictive 
Value of 
Abnormal ST 
Response 
11% 
Relative Risk 
Adjusted for 
the Following 
Variables 
Age, smoking, 
diabetes, family 
history of 
premature heart 
disease, obesity, 
HDL, LDL, 
triglycerides, 
h ertension 
Framingham 
Risk Score 
' 
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